Skip to main content
Fig. 9 | BMC Cancer

Fig. 9

From: Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagy

Fig. 9

LC3-II staining of U87 cells treated with Ad/IL-24. A-E U87 cells were treated with different MOIs of Ad/IL-24 (MOI: 3, 5, and 10) for 48 h, after that expose to secondary antibody staining and analyzed by flow cytometry. Un-treated cells consider as control test. F. Results of compared with the control groups (Un-treated cells consider and Ad/GFP as control groups. ** (P<0.0015), *** (P < 0.003), **** (P<0001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us